Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage

摘要

Compositions and methods directed to the use of adenosine uptake inhibitors for the treatment of retinal and optic nerve head damage following acute or chronic glaucoma, edema, ischemia, hypoxia or trauma are disclosed.